1-4 of 4
Michelle Detry
Close
Sort by
Journal Articles

Fludarabine, Cyclophosphamide, Mitoxantrone Plus Rituximab (FCM-R) as Frontline Therapy for CLL: Results of a Phase 2 Study.

Stefan Faderl, MD, William G. Wierda, MD PhD, Susan O’Brien, MD, Alessandra Ferrajoli, MD, Farhad Ravandi-Kashani, MD, Michelle Detry, PhD, Hagop M. Kantarjian, MD, Brandi O’Neal, RN, Michael J. Keating, MB BS
Journal: Blood
Blood (2006) 108 (11): 2836.
https://doi.org/10.1182/blood.V108.11.2836.2836
Published: 2006
Journal Articles

Long-Term Follow-Up of Allogeneic Stem Cell Transplantation (SCT) with Reduced Intensity Conditioning (RIC) for Patients (pts) with Chronic Myeloid Leukemia (CML).

Partow Kebriaei, MD, Michelle Detry, PhD, Antonio Carrasco-Yalan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Issa Khouri, MD, Paolo Anderlini, MD, Chitra Hosing, MD, Amin Alousi, MD, Sergio Giralt, MD, Richard Champlin, MD, Marcos de Lima, MD
Journal: Blood
Blood (2006) 108 (11): 2898.
https://doi.org/10.1182/blood.V108.11.2898.2898
Published: 2006
Journal Articles

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Marina Motta, MD, William Wierda, MD, PhD, Susan O’Brien, MD, Stefan Faderl, MD, Alessandra Ferrajoli, MD, Michelle Detry, PhD, Susan Lerner, MS, Hagop Kantarjian, MD, Michael Keating, MB, BS
Journal: Blood
Blood (2005) 106 (11): 720.
https://doi.org/10.1182/blood.V106.11.720.720
Published: 2005
Journal Articles

Age Does Not Influence Long-Term Quality of Life (QOL) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for AML/MDS.

Munir Shahjahan, Jorge Alamo, Sergio Giralt, Michelle Detry, Mark Munsell, Elihu Estey, Richard Champlin, Marcos de Lima
Journal: Blood
Blood (2004) 104 (11): 2193.
https://doi.org/10.1182/blood.V104.11.2193.2193
Published: 2004